My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$BXLT {{ '2015-10-29T13:28:00+0000' | timeago}} • Webcast

$BXLT completed the acquisition of ONCASPAR leukemia portfolio from Sigma-Tau Finanziaria. This acquisition includes ONCASPAR, a biologic treatment for acute lymphocytic leukemia (ALL), the investigational biologic calaspargase pegol, and an established oncology infrastructure with clinical and sales resources.

User Ramesh Raju {{ '2017-01-24T08:15:35+0000' | timeago}}

For the combined company, CEO of Altimmune, Bill Enright and CFO of Altimmune, Elizabeth Czerepak, will continue to serve in their respective positions.

User Ramesh Raju {{ '2017-01-24T08:11:25+0000' | timeago}}

Upon completion of the transaction the combined company will trade under the new ticker symbol "ALT." The new company will be based in Gaithersburg, Maryland.

User Ramesh Raju {{ '2017-01-24T07:57:37+0000' | timeago}}

Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

$ZION {{ '2017-01-23T23:14:00+0000' | timeago}} • Webcast

$ZION expects net interest income to increase in the mid to high single digit range, driven mainly by loan and investment securities growth in FY17.

$BRO {{ '2017-01-23T22:58:51+0000' | timeago}} • Announcement

Insurance company $BRO reported a decline in 4Q16 earnings. Net income was $57.7MM, a decrease of 0.7%, and diluted EPS was $0.41, unchanged from 4Q15. Revenues for 4Q16 were $433.6MM, an increase of 7.1%, compared to 4Q15. Organic revenue increased by 3.5% in 4Q16.

$ZION {{ '2017-01-23T22:53:22+0000' | timeago}} • Webcast

$ZION is committing to improve its efficiency ratio to the low 60s in 2017. The company saw soft loan growth in 4Q16, due to the constraints on growth in $ZION's commercial real estate portfolio as a result of internal concentration limits and attrition in oil and gas loans.

$TRST {{ '2017-01-23T22:45:08+0000' | timeago}} • Announcement

$TRST saw solid loan growth in 4Q16 compared to 4Q15, helped by an increase in residential mortgages. Loan portfolio expansion was funded primarily by growth of deposit base. The continued shift toward loans helped offset the margin impact from continued comparatively low yields on cash and investments.

$TRST {{ '2017-01-23T22:44:51+0000' | timeago}} • Announcement

Commercial bank $TRST reported 6.1% rise in its 4Q16 earnings. The company reported net income of $10.8M, or $0.113 per share compared to $10.2MM, or $0.107 during 4Q15. Net interest income rose to $36.9MM during the quarter compared to $36.2MM during 4Q15. Non-interest income rose to $4.51MM from $4.42 during 4Q15.